文献速递妇科

腹腔镜辅助阴式根治性子宫切除术作为早期宫颈癌微创手术的安全选择:一项系统综述与Meta分析

Laparo-assisted vaginal radical hysterectomy as a safe option for minimal invasive surgery in early stage cervical cancer: A systematic review and meta-analysis.
PubMed 文献 · Gynecol Oncol · 2022-09-20

该系统综述与Meta分析检索Pubmed和Scopus数据库至2022年1月,纳入18项研究,其中8项对照研究进入Meta分析,共3033例患者。结果显示腹腔镜辅助阴式根治性子宫切除术(LAVRH)与开腹根治性子宫切除术(ARH)在无病生存期(DFS)上差异无统计学意义(RR 0.82,95%CI 0.55-1.23,P=0.34;I²=0%),总生存期(OS)仅3项研究可合并(RR 1.14,95%CI 0.28-4.67,P=0.43;I²=0%)。作者认为LAVRH似乎不影响早期宫颈癌患者的DFS和OS,结果与LACC试验开腹组相当,但需更多研究验证其安全性和有效性。

要点

  • LAVRH与ARH的DFS差异无统计学意义(RR 0.82,95%CI 0.55-1.23,P=0.34;I²=0%)。
  • OS仅3项研究可合并,LAVRH与ARH差异无统计学意义(RR 1.14,95%CI 0.28-4.67,P=0.43;I²=0%)。
  • 作者认为LAVRH似乎不影响早期宫颈癌的DFS和OS,但需更多研究验证。

核心结论

  • LAVRH似乎不影响早期宫颈癌患者的无病生存期和总生存期,结果与LACC试验开腹组相当,但需更多研究验证其安全性和有效性。

研究设计与样本

  • 遵循PRISMA声明的系统综述与Meta分析,系统检索Pubmed和Scopus数据库至2022年1月,无国家限制,仅纳入英文文章。
  • 纳入包含无病生存期和/或总生存期和/或复发率数据的研究,共18项研究符合纳入标准,其中8项对照研究进入Meta分析,共3033例患者。

主要发现

  • LAVRH与ARH的无病生存期差异无统计学意义(RR 0.82,95%CI 0.55-1.23,P=0.34;I²=0%;P=0.96)。
  • 总生存期仅3项研究可合并,LAVRH与ARH差异无统计学意义(RR 1.14,95%CI 0.28-4.67,P=0.43;I²=0%;P=0.86)。
  • 收集了复发类型(局部区域 vs 远处)的数据。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 作者指出需要更多研究来检验LAVRH在早期宫颈癌中的安全性和有效性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Radical hysterectomy and pelvic lymphadenectomy are considered the standard treatment for early-stage cervical cancer (ECC). Minimal Invasive approach to this surgery has been debated after the publication of a recent prospective randomized trial (Laparoscopic Approach to Cervical Cancer, LACC trial). It demonstrated poorer oncological outcomes for Minimal Invasive Surgery in ECC. However, the reasons are still an open debate. Laparo-Assisted Vaginal Hysterectomy (LAVRH) seems to be a logical option to Abdominal Radical Hysterectomy (ARH). This meta-analysis has the aim to prove it. METHODS: Following the recommendations in the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement, the Pubmed database and Scopus database were systematically searched in January 2022 since early first publications. No limitation of the country was made. Only English article were considered. The studies containing data about Disease-free Survival (DFS) and/or Overall Survival (OS) and/or Recurrence Rate (RcR) were included. RESULTS: 18 studies fulfilled inclusion criteria. 8 comparative studies were enrolled in meta-analysis. Patients were analyzed concerning surgical approach (Laparo-Assisted Vaginal Radical Hysterectomy) and compared with ARH Oncological outcomes such as DFS and OS were considered. 3033 patiets were included. Meta-analysis highlighted a non-statistic significant difference between LARVH and ARH (RR 0.82 [95% CI 0.55-1.23] p = 0.34; I2 = 0%; p = 0.96). OS was feasible only for 3 studies (RR 1.14 [95% CI 0.28-4.67] p = 0.43; I2 = 0 p = 0.86). Data about the type of recurrences (loco-regional vs distant) were collected. CONCLUSION: LARVH does not appear to affect DFS and OS in ECC patients. The proposed results seem to be comparable with the open approach group of the LACC trial, which today represents the reference standard for the treatment of this pathology. More studies will be needed to test the safety and efficacy of LARVH in the ECC.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Ronsini C, Köhler C, de Franciscis P, et al. Laparo-assisted vaginal radical hysterectomy as a safe option for minimal invasive surgery in early stage cervical cancer: A systematic review and meta-analysis. Gynecol Oncol. 2022. PMID: 36150915. doi:10.1016/j.ygyno.2022.09.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。